SG11201507474QA - RIBONUCLEIC ACIDs WITH 4'-THIO-MODIFIED NUCLEOTIDES AND RELATED METHODS - Google Patents
RIBONUCLEIC ACIDs WITH 4'-THIO-MODIFIED NUCLEOTIDES AND RELATED METHODSInfo
- Publication number
- SG11201507474QA SG11201507474QA SG11201507474QA SG11201507474QA SG11201507474QA SG 11201507474Q A SG11201507474Q A SG 11201507474QA SG 11201507474Q A SG11201507474Q A SG 11201507474QA SG 11201507474Q A SG11201507474Q A SG 11201507474QA SG 11201507474Q A SG11201507474Q A SG 11201507474QA
- Authority
- SG
- Singapore
- Prior art keywords
- thio
- modified nucleotides
- related methods
- ribonucleic acids
- ribonucleic
- Prior art date
Links
- 239000002773 nucleotide Substances 0.000 title 1
- 229920002477 rna polymer Polymers 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/02—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/67—General methods for enhancing the expression
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/35—Nature of the modification
- C12N2310/351—Conjugate
- C12N2310/3515—Lipophilic moiety, e.g. cholesterol
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Preparation (AREA)
- Nanotechnology (AREA)
- Optics & Photonics (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361785098P | 2013-03-14 | 2013-03-14 | |
| PCT/US2014/027422 WO2014152513A1 (en) | 2013-03-14 | 2014-03-14 | RIBONUCLEIC ACIDs WITH 4'-THIO-MODIFIED NUCLEOTIDES AND RELATED METHODS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201507474QA true SG11201507474QA (en) | 2015-10-29 |
Family
ID=50639964
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201507474QA SG11201507474QA (en) | 2013-03-14 | 2014-03-14 | RIBONUCLEIC ACIDs WITH 4'-THIO-MODIFIED NUCLEOTIDES AND RELATED METHODS |
Country Status (16)
| Country | Link |
|---|---|
| US (4) | US10266559B2 (en) |
| EP (3) | EP3301102B1 (en) |
| JP (1) | JP6567494B2 (en) |
| KR (1) | KR20150127582A (en) |
| CN (1) | CN105026411A (en) |
| AU (2) | AU2014239562B2 (en) |
| BR (1) | BR112015022507A2 (en) |
| CA (1) | CA2902884C (en) |
| EA (1) | EA201591281A1 (en) |
| ES (2) | ES2797974T3 (en) |
| HK (1) | HK1219955A1 (en) |
| IL (1) | IL240465A0 (en) |
| MX (1) | MX2015011943A (en) |
| SG (1) | SG11201507474QA (en) |
| WO (1) | WO2014152513A1 (en) |
| ZA (1) | ZA201507605B (en) |
Families Citing this family (73)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2782676C (en) | 2009-12-01 | 2021-06-15 | Shire Human Genetic Therapies, Inc. | Pharmaceutical compositions for intracellular delivery of nucleic acids and proteins and uses thereof for treatment of ureca cycle metabolic disorders |
| US8710200B2 (en) | 2011-03-31 | 2014-04-29 | Moderna Therapeutics, Inc. | Engineered nucleic acids encoding a modified erythropoietin and their expression |
| JP6184945B2 (en) | 2011-06-08 | 2017-08-23 | シャイアー ヒューマン ジェネティック セラピーズ インコーポレイテッド | Lipid nanoparticle compositions and methods for mRNA delivery |
| EP4212514A1 (en) | 2011-06-08 | 2023-07-19 | Translate Bio, Inc. | Cleavable lipids |
| EP2833920A2 (en) | 2012-04-02 | 2015-02-11 | Moderna Therapeutics, Inc. | Modified polynucleotides for the production of biologics and proteins associated with human disease |
| US9283287B2 (en) | 2012-04-02 | 2016-03-15 | Moderna Therapeutics, Inc. | Modified polynucleotides for the production of nuclear proteins |
| EP2859102A4 (en) | 2012-06-08 | 2016-05-11 | Shire Human Genetic Therapies | Nuclease resistant polynucleotides and uses thereof |
| EP3446712A1 (en) | 2013-03-14 | 2019-02-27 | Translate Bio Ma, Inc. | Cftr mrna compositions and related methods and uses |
| US9957499B2 (en) | 2013-03-14 | 2018-05-01 | Translate Bio, Inc. | Methods for purification of messenger RNA |
| US10590161B2 (en) | 2013-03-15 | 2020-03-17 | Modernatx, Inc. | Ion exchange purification of mRNA |
| WO2014152030A1 (en) | 2013-03-15 | 2014-09-25 | Moderna Therapeutics, Inc. | Removal of dna fragments in mrna production process |
| EP4279610A3 (en) | 2013-03-15 | 2024-01-03 | ModernaTX, Inc. | Ribonucleic acid purification |
| EP2971033B8 (en) | 2013-03-15 | 2019-07-10 | ModernaTX, Inc. | Manufacturing methods for production of rna transcripts |
| WO2014197578A1 (en) * | 2013-06-05 | 2014-12-11 | Idenix Pharmaceuticals, Inc. | 1',4'-thio nucleosides for the treatment of hcv |
| EP3019619B1 (en) | 2013-07-11 | 2021-08-25 | ModernaTX, Inc. | Compositions comprising synthetic polynucleotides encoding crispr related proteins and synthetic sgrnas and methods of use |
| EP3052511A4 (en) | 2013-10-02 | 2017-05-31 | Moderna Therapeutics, Inc. | Polynucleotide molecules and uses thereof |
| EA201690675A1 (en) | 2013-10-03 | 2016-08-31 | Модерна Терапьютикс, Инк. | POLYNUCLEOTES ENCODING THE RECEPTOR OF LOW DENSITY LIPOPROTEINS |
| WO2015061491A1 (en) | 2013-10-22 | 2015-04-30 | Shire Human Genetic Therapies, Inc. | Mrna therapy for phenylketonuria |
| CN106413811A (en) | 2013-10-22 | 2017-02-15 | 夏尔人类遗传性治疗公司 | Mrna therapy for argininosuccinate synthetase deficiency |
| CN110511927A (en) | 2014-04-25 | 2019-11-29 | 川斯勒佰尔公司 | The purification process of mRNA |
| EP3157573A4 (en) | 2014-06-19 | 2018-02-21 | Moderna Therapeutics, Inc. | Alternative nucleic acid molecules and uses thereof |
| JP2017522028A (en) | 2014-07-16 | 2017-08-10 | モデルナティエックス インコーポレイテッドＭｏｄｅｒｎａＴＸ，Ｉｎｃ． | Circular polynucleotide |
| GB201508025D0 (en) | 2015-05-11 | 2015-06-24 | Ucl Business Plc | Fabry disease gene therapy |
| SI3350333T1 (en) | 2015-09-17 | 2022-04-29 | ModernaTX,Inc. | Polynucleotides containing a stabilizing tail region |
| US11434486B2 (en) | 2015-09-17 | 2022-09-06 | Modernatx, Inc. | Polynucleotides containing a morpholino linker |
| MA43568A (en) | 2015-12-17 | 2018-11-14 | Modernatx Inc | POLYNUCLEOTIDES CODING FOR METHYLMALONYL-COA MUTASE |
| US20210206818A1 (en) | 2016-01-22 | 2021-07-08 | Modernatx, Inc. | Messenger ribonucleic acids for the production of intracellular binding polypeptides and methods of use thereof |
| CA3020343A1 (en) | 2016-04-08 | 2017-10-12 | Translate Bio, Inc. | Multimeric coding nucleic acid and uses thereof |
| US20190167811A1 (en) | 2016-04-13 | 2019-06-06 | Modernatx, Inc. | Lipid compositions and their uses for intratumoral polynucleotide delivery |
| CA3024470A1 (en) | 2016-05-18 | 2017-11-23 | Modernatx, Inc. | Polynucleotides encoding interleukin-12 (il12) and uses thereof |
| MA45053A (en) | 2016-05-18 | 2019-03-27 | Modernatx Inc | POLYNUCLEOTIDES CODING FOR A CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR FOR THE TREATMENT OF CYSTIC FIBROSIS |
| WO2017201328A1 (en) | 2016-05-18 | 2017-11-23 | Modernatx, Inc. | POLYNUCLEOTIDES ENCODING α-GALACTOSIDASE A FOR THE TREATMENT OF FABRY DISEASE |
| DK3585891T3 (en) | 2017-02-27 | 2021-11-22 | Translate Bio Inc | METHODS FOR PURIFICATION OF MESSENGER RNA |
| DK3585892T3 (en) | 2017-02-27 | 2022-08-22 | Translate Bio Inc | METHODS FOR PURIFICATION OF MESSENGER RNA |
| CA3054062A1 (en) | 2017-02-27 | 2018-08-30 | Translate Bio, Inc. | Novel codon-optimized cftr mrna |
| WO2018165257A1 (en) | 2017-03-07 | 2018-09-13 | Translate Bio, Inc. | Polyanionic delivery of nucleic acids |
| FR3066115B1 (en) * | 2017-05-10 | 2019-06-28 | Universite de Bordeaux | COMPRESSES OF NUCLEIC ACID VECTORS |
| AU2018268859B2 (en) | 2017-05-16 | 2024-07-25 | Translate Bio, Inc. | Treatment of cystic fibrosis by delivery of codon-optimized mrna encoding CFTR |
| MX2019014412A (en) | 2017-05-31 | 2020-02-10 | Ultragenyx Pharmaceutical Inc | Therapeutics for glycogen storage disease type iii. |
| EP3638716B1 (en) | 2017-06-12 | 2022-01-05 | Translate Bio, Inc. | Poly(phosphoesters) for delivery of nucleic acids |
| WO2018231990A2 (en) | 2017-06-14 | 2018-12-20 | Modernatx, Inc. | Polynucleotides encoding methylmalonyl-coa mutase |
| WO2018236849A1 (en) | 2017-06-19 | 2018-12-27 | Translate Bio, Inc. | Messenger rna therapy for the treatment of friedreich's ataxia |
| MA50803A (en) | 2017-11-22 | 2020-09-30 | Modernatx Inc | POLYNUCLEOTIDES CODING ORNITHINE TRANSCARBAMYLASE FOR THE TREATMENT OF UREA CYCLE DISORDERS |
| MA50801A (en) | 2017-11-22 | 2020-09-30 | Modernatx Inc | POLYNUCLEOTIDES CODING FOR PHENYLALANINE HYDROXYLASE FOR THE TREATMENT OF PHENYLKETONURIS |
| EP3746496A1 (en) | 2018-02-02 | 2020-12-09 | Translate Bio, Inc. | Cationic polymers |
| AU2019271132A1 (en) * | 2018-05-15 | 2020-11-12 | Translate Bio, Inc. | Subcutaneous delivery of messenger RNA |
| AU2019271215B2 (en) | 2018-05-16 | 2024-09-12 | Translate Bio, Inc. | Ribose cationic lipids |
| JP7488193B2 (en) | 2018-05-24 | 2024-05-21 | トランスレイト バイオ， インコーポレイテッド | Thioester Cationic Lipids |
| KR20210056953A (en) * | 2018-05-30 | 2021-05-20 | 트랜슬레이트 바이오 인코포레이티드 | Messenger RNA vaccine and uses thereof |
| WO2019232097A1 (en) | 2018-05-30 | 2019-12-05 | Translate Bio, Inc. | Phosphoester cationic lipids |
| CA3100214A1 (en) | 2018-05-30 | 2019-12-05 | Translate Bio, Inc. | Cationic lipids comprising a steroidal moiety |
| CA3101478A1 (en) | 2018-05-30 | 2019-12-05 | Translate Bio, Inc. | Vitamin cationic lipids |
| CN112638362A (en) * | 2018-07-23 | 2021-04-09 | 川斯勒佰尔公司 | Dry powder formulations of messenger RNA |
| AU2019325702A1 (en) | 2018-08-24 | 2021-02-25 | Translate Bio, Inc. | Methods for purification of messenger RNA |
| MX2021003421A (en) | 2018-09-28 | 2021-06-15 | Nutcracker Therapeutics Inc | Lipid nanoparticle formulations comprising lipidated cationic peptide compounds for nucleic acid delivery. |
| EA202190688A1 (en) | 2018-10-09 | 2021-06-07 | Дзе Юниверсити Оф Бритиш Коламбиа | COMPOSITIONS AND SYSTEMS CONTAINING TRANSFECTIONALLY COMPETENT VESICULES, NOT CONTAINING ORGANIC SOLVENTS AND DETERGENTS, AND RELATED METHODS |
| CA3115119A1 (en) | 2018-11-08 | 2020-05-14 | Translate Bio, Inc. | Methods and compositions for messenger rna purification |
| EP3876994A2 (en) | 2018-11-09 | 2021-09-15 | Translate Bio, Inc. | Peg lipidoid compounds |
| EP3877444A1 (en) | 2018-11-09 | 2021-09-15 | Translate Bio, Inc. | Multi-peg lipid compounds |
| EP3877368A1 (en) | 2018-11-09 | 2021-09-15 | Translate Bio, Inc. | 2,5-dioxopiperazine lipids with intercalated ester, thioester, disulfide and anhydride moieities |
| ES2971849T3 (en) | 2018-11-21 | 2024-06-10 | Translate Bio Inc | Cationic lipid compounds and compositions thereof for use in the delivery of messenger RNA |
| EP3956303A1 (en) | 2019-04-18 | 2022-02-23 | Translate Bio, Inc. | Cystine cationic lipids |
| ES2972014T3 (en) | 2019-04-22 | 2024-06-10 | Translate Bio Inc | Thioester cationic lipids |
| US20220257724A1 (en) | 2019-05-03 | 2022-08-18 | Translate Bio, Inc. | Di-thioester cationic lipids |
| US20220226244A1 (en) | 2019-05-31 | 2022-07-21 | Translate Bio, Inc. | Macrocyclic lipids |
| WO2020257611A1 (en) | 2019-06-21 | 2020-12-24 | Translate Bio, Inc. | Cationic lipids comprising an hydroxy moiety |
| AU2020297606A1 (en) | 2019-06-21 | 2022-01-20 | Translate Bio, Inc. | Tricine and citric acid lipids |
| CN111041025B (en) | 2019-12-17 | 2021-06-18 | 深圳市瑞吉生物科技有限公司 | mRNA targeting molecule based on combination of N-acetylgalactosamine polypeptide and preparation method thereof |
| WO2021202788A2 (en) * | 2020-04-03 | 2021-10-07 | Ionis Pharmaceuticals, Inc. | Modified oligomeric compounds and uses thereof |
| WO2021231697A1 (en) | 2020-05-14 | 2021-11-18 | Translate Bio, Inc. | Peg lipidoid compounds |
| CN111744019B (en) | 2020-07-01 | 2023-08-04 | 深圳瑞吉生物科技有限公司 | Mannose-based mRNA targeted delivery system and application thereof |
| CN114736260B (en) * | 2022-03-29 | 2024-08-23 | 上海吉量医药工程有限公司 | Preparation method of nucleotide triphosphate |
| WO2023239190A1 (en) * | 2022-06-10 | 2023-12-14 | 주식회사 피노바이오 | Method for preparing 4'-thio-5-aza-2'-deoxycytidine |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ210501A (en) * | 1983-12-13 | 1991-08-27 | Kirin Amgen Inc | Erythropoietin produced by procaryotic or eucaryotic expression of an exogenous dna sequence |
| FR2687679B1 (en) | 1992-02-05 | 1994-10-28 | Centre Nat Rech Scient | OLIGOTHIONUCLEOTIDES. |
| AU2004274021B2 (en) * | 2003-09-18 | 2009-08-13 | Isis Pharmaceuticals, Inc. | 4'-thionucleosides and oligomeric compounds |
| WO2008103276A2 (en) * | 2007-02-16 | 2008-08-28 | Merck & Co., Inc. | Compositions and methods for potentiated activity of biologicaly active molecules |
| US8969353B2 (en) | 2008-11-07 | 2015-03-03 | Massachusetts Institute Of Technology | Aminoalcohol lipidoids and uses thereof |
| DE102009032885A1 (en) | 2009-07-13 | 2011-02-03 | Siemens Aktiengesellschaft | Ring-shaped rotor for an electric machine |
| CA2782676C (en) | 2009-12-01 | 2021-06-15 | Shire Human Genetic Therapies, Inc. | Pharmaceutical compositions for intracellular delivery of nucleic acids and proteins and uses thereof for treatment of ureca cycle metabolic disorders |
| EP4212514A1 (en) | 2011-06-08 | 2023-07-19 | Translate Bio, Inc. | Cleavable lipids |
| JP6184945B2 (en) | 2011-06-08 | 2017-08-23 | シャイアー ヒューマン ジェネティック セラピーズ インコーポレイテッド | Lipid nanoparticle compositions and methods for mRNA delivery |
| EP4015005A1 (en) | 2011-10-03 | 2022-06-22 | ModernaTX, Inc. | Modified nucleosides, nucleotides, and nucleic acids, and uses thereof |
| EP3052511A4 (en) | 2013-10-02 | 2017-05-31 | Moderna Therapeutics, Inc. | Polynucleotide molecules and uses thereof |
| US20160264614A1 (en) | 2013-10-02 | 2016-09-15 | Moderna Therapeutics, Inc. | Polynucleotide molecules and uses thereof |
| EP2918275B1 (en) | 2013-12-13 | 2016-05-18 | Moderna Therapeutics, Inc. | Alternative nucleic acid molecules and uses thereof |
| WO2016164762A1 (en) | 2015-04-08 | 2016-10-13 | Moderna Therapeutics, Inc. | Polynucleotides encoding low density lipoprotein receptor egf-a and intracellular domain mutants and methods of using the same |
-
2014
- 2014-03-14 EP EP17189627.7A patent/EP3301102B1/en active Active
- 2014-03-14 EP EP14721635.2A patent/EP2970351B1/en active Active
- 2014-03-14 JP JP2016502430A patent/JP6567494B2/en active Active
- 2014-03-14 BR BR112015022507A patent/BR112015022507A2/en not_active IP Right Cessation
- 2014-03-14 ES ES17189627T patent/ES2797974T3/en active Active
- 2014-03-14 CN CN201480010106.8A patent/CN105026411A/en active Pending
- 2014-03-14 AU AU2014239562A patent/AU2014239562B2/en active Active
- 2014-03-14 CA CA2902884A patent/CA2902884C/en active Active
- 2014-03-14 US US14/776,506 patent/US10266559B2/en active Active
- 2014-03-14 ES ES14721635.2T patent/ES2647832T3/en active Active
- 2014-03-14 WO PCT/US2014/027422 patent/WO2014152513A1/en active Application Filing
- 2014-03-14 SG SG11201507474QA patent/SG11201507474QA/en unknown
- 2014-03-14 MX MX2015011943A patent/MX2015011943A/en unknown
- 2014-03-14 EP EP20169380.1A patent/EP3750903A1/en active Pending
- 2014-03-14 KR KR1020157021965A patent/KR20150127582A/en not_active Application Discontinuation
- 2014-03-14 EA EA201591281A patent/EA201591281A1/en unknown
-
2015
- 2015-08-10 IL IL240465A patent/IL240465A0/en unknown
- 2015-10-13 ZA ZA2015/07605A patent/ZA201507605B/en unknown
-
2016
- 2016-07-07 HK HK16107939.1A patent/HK1219955A1/en unknown
-
2018
- 2018-06-05 AU AU2018203985A patent/AU2018203985B2/en active Active
-
2019
- 2019-02-21 US US16/282,106 patent/US10822368B2/en active Active
-
2020
- 2020-09-25 US US17/032,485 patent/US11447520B2/en active Active
-
2022
- 2022-08-10 US US17/818,858 patent/US20230192753A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2018203985A1 (en) | 2018-06-21 |
| AU2014239562A1 (en) | 2015-08-27 |
| EP2970351A1 (en) | 2016-01-20 |
| HK1219955A1 (en) | 2017-04-21 |
| US20210009629A1 (en) | 2021-01-14 |
| US10822368B2 (en) | 2020-11-03 |
| EP2970351B1 (en) | 2017-09-13 |
| CA2902884C (en) | 2021-05-25 |
| US10266559B2 (en) | 2019-04-23 |
| EP3301102A1 (en) | 2018-04-04 |
| MX2015011943A (en) | 2015-12-01 |
| CA2902884A1 (en) | 2014-09-25 |
| WO2014152513A1 (en) | 2014-09-25 |
| IL240465A0 (en) | 2015-09-24 |
| BR112015022507A2 (en) | 2017-10-24 |
| ES2647832T3 (en) | 2017-12-26 |
| EP3301102B1 (en) | 2020-04-15 |
| EP3750903A1 (en) | 2020-12-16 |
| US20230192753A1 (en) | 2023-06-22 |
| EA201591281A1 (en) | 2016-02-29 |
| AU2018203985B2 (en) | 2019-09-19 |
| US11447520B2 (en) | 2022-09-20 |
| CN105026411A (en) | 2015-11-04 |
| AU2014239562B2 (en) | 2018-07-05 |
| US20190263850A1 (en) | 2019-08-29 |
| KR20150127582A (en) | 2015-11-17 |
| JP6567494B2 (en) | 2019-08-28 |
| ES2797974T3 (en) | 2020-12-04 |
| ZA201507605B (en) | 2017-01-25 |
| US20160031928A1 (en) | 2016-02-04 |
| JP2016513470A (en) | 2016-05-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201507605B (en) | Ribonucleic acids with 4'-thio-modified nucleotides and related methods | |
| IL269461B (en) | Cytidine-5-carboxamide modified nucleotide compositions and methods related thereto | |
| IL236616B (en) | 5-aminotetrahydroquinoline-2-carboxylic acids and use thereof | |
| SG11201603144QA (en) | Artificial nucleic acid molecules | |
| IL230135A0 (en) | Catheter with multiple spines of different lengths arranged in one or more distal assemblies | |
| IL245839A0 (en) | Rna polymerase i inhibitors and uses thereof | |
| EP2953558A4 (en) | Embryo transfer catheter and method | |
| HK1216979A1 (en) | Garment part with fastening system and manufacturing method thereof | |
| EP3078747A4 (en) | Peanut-binding nucleic acid molecule and use thereof | |
| GB2517910B (en) | Improvements in or relating to fasteners | |
| PT2980096T (en) | 2 ,3 ,5 -trihydroxy-androst-6-one and preparation methods and use thereof | |
| GB2519772B (en) | Improvements in or relating to animal apparel | |
| GB201307664D0 (en) | Methods and compostions for identifying nucleic acids | |
| HK1214302A1 (en) | Isolated oligonucleotide and use thereof | |
| GB201307840D0 (en) | Improved bacteriophage delivery and nucleic acid expression | |
| GB2537765B (en) | Improvements in or relating to animal apparel | |
| GB201321889D0 (en) | Desaturase nucleic acids | |
| GB201321786D0 (en) | Desaturase nucleic acids | |
| GB201306288D0 (en) | Gene targeting in animals | |
| IL240422A0 (en) | Biaryl-propionic acid derivatives and their use as pharmaceuticals | |
| GB201315594D0 (en) | Improvements in or relating to signage | |
| GB201303902D0 (en) | Official's hawk | |
| GB201303827D0 (en) | The sleep easy | |
| AP2015008228A0 (en) | Novel 5-aminotetrahydroquinoline-2-carboxylic acids and use thereof | |
| GB201314682D0 (en) | Rhamnosyltransferase polypeptides and nucleic acids |